Quantum-P rose more than 9% after the market closed, after reaching a technical cooperation with N1 Life. CICC said the company is expected to enter the primary market.

QUANTUMPH-P(02228) rose more than 9% in the afternoon, hitting a new high of HK$6.83, and as of the time of writing, it was up 9.28% at HK$6.83, with a turnover of HK$13.73mn.

On the news front, N1Life and JingTai Technology announced a technical cooperation. The two sides will jointly use N1Life's multi-oligonucleotide library developed and accumulated over the years with Stanford University, and JingTai Technology's multi-oligonucleotide molecular design and screening platform to achieve AI-driven platform drug delivery oligonucleotide design, improve the drugability of RNA and accelerate the development process of new ophthalmic drugs.

In addition, CICC published a report saying that after the closing of the stock market on August 16, Hang Seng Index Company will announce the half-year review results of Hang Seng series indices, including Hang Seng, H-share, Hang Seng Technology, etc., major stock indices, and Hang Seng Composite Index, which is closely related to the investment scope of H-share. CICC expects that 25 companies will be included in H-share, including QUANTUMPH-P.